1.Ethics Thinking on Construction of Medical Dispute Prevention and Control Mechanism Under the Perspective of Crisis Management
Chinese Medical Ethics 2015;(5):712-714
Discussion on the construction of medical dispute prevention and control mechanism from the per -spective of crisis management and the ethical thinking are conducive to the effective prevention , control and solution of medical disputes .This can promote the healthy development of the doctor -patient relationship and has the im-portant value of ethics .At present , should strengthen the crisis management from the aspect of ethics to control medical disputes in the following aspects: establishing the medical dispute crisis -prevention mechanism by strengthening the training of medical staff′s medical ethics and medical skill;establishing the medical dispute crisis-resolution mechanism under the principle of respect for life and the patient first;establishing the medical dispute crisis assessment and post -processing mechanism around the idea of love , gratitude , and excellence development .
2.Analysis for changes in awareness and behavior of prevention and treatment for hypertension in an urban community of Beijing
Kai WANG ; Hongjin MA ; Dahong TU
Chinese Journal of General Practitioners 2003;0(04):-
Objective To study the effects of health promotion on prevention and treatment for hypertension in urban population performed by a community hospital. Methods Typical sampling was used to select 318 subjects in a sub-district government office of Chongwen District in Beijing and a factory under jurisdiction of the city as intervention community. Comprehensive intervention for hypertension was performed at this community during July 2003 to December 2004. All the subjects were interviewed with questionnaire of knowledge of hypertension and its behavioral risk factors before and after intervention. The data were analyzed with SPSS version 11.0. Results Totally, 272 of 318 subjects responded after intervention. Awareness of prevention and treatment for hypertension in the subjects was compared before and after intervention. Awareness of the harm of high blood pressure in the subjects increased to 60 percent after intervention from 51 percent before it (P
3.On hemolysis of extracts of Lonicera Macranthoides flower bud and two saponins
Hongjin WANG ; Hongyu WANG ; Ran HE ; Junjie WU ; Xiaoyu XU
Chinese Pharmacological Bulletin 2016;(1):43-48
Aim To figure out whether Lonicera mac-ranthoides could induce hemolysis. Methods In vitro, macroscopic observation and spectrophotometry were used to observe whether the solutions of extracts from Lonicera macranthoides, MacranthoidinB and Dipsa-cosideB could induce hemolysis in 2% red cell suspen-sion of New Zealand white rabbits. And the three test-ed materials were prepared in concentration gradient of 5, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100 mg· L - 1; and in vivo, mice were respectively treated with MacranthoidinB (0. 110 g·kg - 1 , 0. 055 g·kg - 1 ), DipsacosideB(0. 020 g·kg - 1 , 0. 010 g·kg - 1 ), ex-tracts (2. 275 g·kg - 1 , 1. 137 g·kg - 1 , crude drugs) once per day for 7 days, and all of the tested doses de-pended on the clinical doses. Then, RBC, RET and MCHC before and after administration were tested. Re-sults The hemolytic ratio in each treated group was below 5% in vitro. And in vivo, the three materials did not induce hemolysis and had no significant influence on RBC,RET and MCHC(P > 0. 05). Conclusions Extracts from flower bud of Lonicera macranthoides, MacranthoidinB and DipsacosideB, have not caused hemolysis in vivo and in vitro in this research.
4.RFID-Based Intelligent Medicine-Chest for Combat Readiness
Jiangning BIAN ; Xin LAI ; Zhanao WU ; Hongjin WANG ; Gang WANG
Chinese Medical Equipment Journal 2004;0(08):-
Objective To provide information collection,processing and inquiry system,which is safe,accurate rapid and in real time,for combat readiness medical supplies.Methods RFID technology and series antenna coils separated in space were used in combat readiness medicine-chest,thus enabling the medicine-chest to have the virtue of intelligence.Results The combat readiness medicine-chest equipped with RFID system can automatically classify to count and manage medical supplies in medicine-chest without opening the chest.The medical supplies can be monitored in real time and the information of outdated medicine can be automatically prompted.Conclusion Intelligent medicine-chest based on RFID technology can provide informatized method and technique for the management of combat readiness medical supplies for PLA.
5.Research on Locating Technology of Medicine in Intelligent Medicine Cabinet
Hongjin WANG ; Xin LAI ; Zhanao WU ; Gang WANG
Chinese Medical Equipment Journal 2004;0(09):-
Objective To identify the location of medicines in combat readiness medicine cabinet.Methods RFID system was used in combination with series antennas separated in space in combat readiness medicine cabinet.Results The combat readiness medicine cabinet equipped with RFID system could identify the location of medicines in medicine cabinet.It realized the location management and automatic classification statistics for medicines without opening cabinet.It greatly shortened the time in taking medicine in field emergency care.Conclusion Intelligent medicine cabinet based on RFID technology can upgrade the modernization level of sanitation logistics and provide a modern management method for iatrical material of combat readiness of PLA.
6.Design of RFID Reader Antenna for Multi-Drawer Intelligent Medicine-Chest
Yi ZHU ; Xin LAI ; Hongjin WANG ; Gang WANG
Chinese Medical Equipment Journal 2003;0(12):-
Objective In order to increase the operation coverage of high-frequency (HF) RFID reader without increasing the power output, a novel RFID antenna for multi-drawer intelligent medicine-chest are proposed. Using this antenna, the RFID tags on medicine can be read effectively. Methods Several small antenna coils can be combined in series or parallel connection to make a more efficient RFID reader antenna. The use of small coil will be helpful to eliminate the blind spot of RFID reader with large coil antenna. Results The medicine-chest's size is 58 cm?50 cm?62 cm3, which includes two or three layers. We design four combined small antenna coils to cover the drawer. The test result shows that the antenna read region is about 54 cm?48 cm?30 cm, all RFID tags in the medicine-chest drawer bottom and most RFID tags in the drawer top can be read. Conclusion The multi-drawer coil antenna designed can effectively recognize the RFID tags in medicine-chest. It has a wide application prospect.
7.Optimization of Ethanol Mixed-extraction Technology of Red ginseng and Salvia miltiorrhiza in Xinlikang Granules by Multiple Indexes Comprehensive Evaluation Method Combined with Orthogonal Test
Shaochen WANG ; Yujie GUO ; Ye REN ; Hongjin WU ; Jianxun LIU
China Pharmacy 2016;27(19):2678-2680,2681
OBJECTIVE:To optimize the ethanol mixed-extraction technology of Red ginseng and Salvia miltiorrhiza in Xin-likang granules. METHODS:L9(34)orthogonal test was adopted to optimize ethanol mixed-extraction technology with ethanol vol-ume fraction,amount of ethanol and extraction times as factors using weighting coefficient comprehensive score of the contents of ginsenoside Rg1,Re and Rb1 in R. ginseng and the contents of tanshinone ⅡA and salvianolic acid B in S. miltiorrhiza as index;and the verification test was detected. RESULTS:Optimal mixed-ethanol extraction technology was as follows as 6-fold 70% etha-nol,reflux extracting for 3 times,2 h each time. In verification test,average contents of ginsenosides Rg1,Re,Rb1 in R. ginseng and those of tanshinone ⅡA and salvianolic acid B in S. miltiorrhiza were 3.963 8,0.757 3,4.986 2,0.964 7,27.662 5 mg/g,re-spectively,and comprehensive score was 0.96 (RSD=1.26%,n=3). CONCLUSIONS:Ethanol extraction technology of R. gin-seng and S. miltiorrhiza in Xinlikang granules optimized by multiple indexes comprehensive score combined with orthogonal test is stable,reasonable and feasible.
8.Preparation and identification of anti human myocardium troponin I monoclonal antibodies
Baoming JIAO ; Zhiliang LI ; Qing LU ; Hongjin QIAN ; Ning ZHOU ; Suhua WANG ; Xuexian QIAN
Academic Journal of Second Military Medical University 2001;22(4):376-377
Objective: To prepare monoclonal antibodies (McAb) with cardiac troponin I (cTnI) which was purified from fresh human cardiac muscle within 6 h. Methods: (1) Extraction and purification of human cTnI: cTnI was purified by high salt extraction, saltless precipitation, 65℃ treatment, ammonium sulfate fractionation and DEAE-cellulose chromatography, etc. (2) Preparation of anti human cTnI McAb: The purified cTnI was injected into the spleen of BALB/c mice. The cTnI-primed spleen cells were fused with Sp2/0 myoloma cell. The McAbs anti human cTnI were obtained by screening with indirect ELISA and 3 times clone. (3)The identification of anti cTnI McAb. Results: Five hybridoma cell lines, named 3A7,3A11,3D2,3F10 and 1H9 were developed, which could secret McAb stably. The 5 McAbs all were demonstrated to be IgG2a by double gel diffusion test. The number of hybridoma chromosomes was between 92 to 110 and the chromosomes were mainly telocentric. Five kinds of ascites had no cross-reaction to LDH,CK,CK-MB ,AST and cardiac troponin T(cTnT), and their titers were between 3.2×10-6 to 1.6×10-7. Conclusion: 3D2,3F10 and 3A7,3A11,1H9 react to different epitopes of cTnI.
9.Analysis of clinical characteristics and treatment effect of perianal Crohn's disease with or without proctitis
Ping ZHU ; Yugen CHEN ; Yunfei GU ; Minmin XU ; Hao WANG ; Hongjin CHEN ; Bolin YANG
Chinese Journal of Digestive Surgery 2016;15(12):1170-1175
Objective To investigate the clinical characteristics of perianal Crohn's disease (CD) with or without proctitis and compare the treatment effect of surgery combined with biological preparation.Methods The retrospective cohort study was conducted.The clinical data of 52 patients with perianal CD who were admitted to the Affiliated Hospital of Nanjing University of Traditional Chinese Medicine from June 2011 to October 2014 were collected.Thirty patients with inflammation involvement of the rectum and 22 patients without inflammation involvement of the rectum were respectively divided into the proctitis group and non-proctitis group.All the 52 patients underwent surgery combined with infliximab therapy.Observation indicators included:(1) clinical characteristics:gender,age,body mass index (BMI),lesion location,disease behavior,type of perianal lesions,history of perianal surgeries,CD activity index (CDAI),perianal disease activity index (PDAI),C-reactive protein (CRP),erythrocyte sedimentation rate (ESR),white blood cell (WBC),platelet (PLT) and albumin (Alb),(2) treatment and follow-up.Follow-up using outpatient examination was performed to evaluate the perianal lesions up to December 2015.Measurement data with normal distribution were described as-x ± s and comparison between groups was analyzed by the t test.Count data were described as the percentage,and comparison between groups was analyzed by the chi-square test and Fisher's exact probability.Results (1)Clinical characteristics:number of patients with BMI < 18.5 kg/m2 and with normal BMI were respectively 17,13 in the proctitis group and 6,16 in the non-proctitis group.Lesions located at ileum,colon and ileocolon were respectively detected in 3,9,18 patients in the proctitis group and 9,4,9 patients in the non-proctitis group.CDAI≥ 150 and < 150,CRP≥8 mg/L and < 8 mg/L,ESR > normal level and =normal level,Alb < 35 g/L and between 35 g/L and 50 g/L were respectively detected in 23,7,25,5,24,6,12,18 patients in the proctitis group and 8,14,8,14,8,14,2,20 in the non-proctitis group,with statistically significant differences between the 2 groups (x2 =4.446,6.855,8.563,12.076,10.211,6.163,P < 0.05).(2) Treatment and follow-up:all the 52 patients underwent more than 3 times infliximab therapies and perianal surgeries within 1 week after infliximab therapy.All the patients were followed up for a median time of 28 months (range,8-52 months).Thirty-four patients still underwent maintenance therapy of immunosuppressive agents and 18 didn't undergo maintenance therapy up to the end of follow-up.Twenty-two patients in the proctitis group and 12 patients in the non-proctitis group underwent maintenance therapy,with no statistically significant difference between the 2 groups (x2 =1.979,P > 0.05).The total healed rate,improvement rate and unhealed rate of perianal lesion were 55.8% (29/52),34.6% (18/52) and 9.6% (5/52),respectively.The number of patients with healed,improved and unhealed perianal lesions were 16,11,3 in the proctitis group and 13,7,2 in the non-proctitis group,respectively,showing no significant difference in treatment effects between the 2 groups (x2 =O.173,P > 0.05).Conclusions Patients with perianal CD combined with proctitis have higher activity of intestinal inflammation and worse nutritional status compared with patients without proctitis.However,there is no significant difference in the type and activity of perianal lesion between patients with or without proctitis.Surgery combined with biological preparation could render better clinical outcomes in treatment of perianal CD with proctitis.
10.Exon deletions of parkin gene in patients with Parkinson disease.
Tao, WANG ; Zhihou, LIANG ; Shenggang, SUN ; Xuebing, CAO ; Hai, PENG ; Hongjin, LIU ; Etang, TONG
Journal of Huazhong University of Science and Technology (Medical Sciences) 2004;24(3):262-5
Mutations in the parkin gene have recently been identified in familial and isolated patients with early-onset Parkinson disease (PD) and that subregions between exon 2 and 4 of the parkin gene are hot spots of deletive mutations. To study the distribution of deletions in the parkin gene among variant subset patients with PD in China, and to explore the role of parkin gene in the pathogenesis of PD, 63 patients were divided into early onset and later onset groups. Exons 1-12 were amplified by PCR, templated by the genomic DNA of patients, and then the deletion distribution detected by agarose electrophoresis. Four patients were found to be carrier of exon deletions in 63 patients with PD. The location of the deletion was on exon 2 (1 case), exon 3 (2 cases) and exon 4 (1 case). All patients were belong to the group of early onset PD. The results showed that parkin gene deletion on exon 2, exon 3 and exon 4 found in Chinese population contributes partly to early onset PD.
Exons/*genetics
;
*Gene Deletion
;
Parkinson Disease/*genetics
;
Point Mutation
;
Ubiquitin-Protein Ligases/*genetics